Finance

Lists
VERA:NASDAQ
Vera Therapeutics, Inc
$29.99
-0.99%
(-0.30) 1D
$30.01
+0.07% (+0.020)
After hours
Closed: Aug 12, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VERA...
Open
$30.74
High
$31.18
Low
$29.71
Mkt. cap
2.16B
Avg. vol.
2.32M
Volume
1.68M
52-wk high
$56.05
52-wk low
$21.04
EPS
-$5.86
Beta
0.92
Shares outstanding
72.06M
No. of employees
339
Open
$30.74
High
$31.18
Low
$29.71
Mkt. cap
2.16B
Avg. vol.
2.32M
Volume
1.68M
52-wk high
$56.05
52-wk low
$21.04
EPS
-$5.86
Beta
0.92
Shares outstanding
72.06M
No. of employees
339
News stories
From web sources and news partners
About Vera Therapeutics, Inc
CEO-
Employees339
Founded2016
HeadquartersBrisbane, California, United States
SectorBiotechnology
Websiteveratx.com
Analyst ratings
Based on 14 analysts giving stock ratings to VERA in the past 3 months
Strong buy
Buy
13
Hold
1
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for VERA in the last 3 months.
Highest
Current $29.99
$100.00 (+233.44%)
Average
$78.71 (+162.45%)
Lowest
$34.00 (+13.37%)
Analyst
Recommendation
Action
Price target
Projected
Date
Mohit Bansal
Wells Fargo
Buy
Reiterated
$70.00
+133.4%
08/12/2026
Arthur He CFA
H.C. Wainwright
Buy
Reiterated
$90.00
+200.1%
08/12/2026
Ritu Baral
TD Cowen
Buy
Maintained
$78.00
+160.1%
08/11/2026
Unknown Analyst
Jefferies
Buy
Maintained
$59.00
+96.7%
08/11/2026
Ryan Deschner
Raymond James
Buy
Reiterated
$84.00
+180.1%
08/11/2026
Pete Stavropoulos
Cantor Fitzgerald
Buy
Maintained
$100.00
+233.4%
08/10/2026
Laura Chico
Wedbush
Hold
Maintained
$34.00
+13.4%
08/11/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
$90.00
+200.1%
08/11/2026
Dina Ramadane
Bank of America Securities
Buy
Reiterated
$66.00
+120.1%
08/10/2026
Gavin Clark-Gartner
Evercore ISI
Buy
Maintained
$91.00
+203.4%
07/09/2026
Vamil Divan
Guggenheim
Buy
Reiterated
$76.00
+153.4%
07/08/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
$70.00
+133.4%
06/11/2026
Paul Choi
Goldman Sachs
Buy
Maintained
$90.00
+200.1%
06/05/2026
Andy Chen
Wolfe Research
Buy
Maintained
$88.00
+193.4%
06/02/2026
Anupam Rama
J.P. Morgan
Buy
Maintained
$86.00
+186.8%
05/22/2026
Unknown Analyst
Wedbush
Hold
Maintained
$35.00
+16.7%
05/08/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
58.20M
56.47M
59.31M
86.01M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
21.95M
27.46M
34.90M
39.12M
Operating expense
80.14M
83.93M
94.21M
125.13M
Total operating expenses
80.14M
83.93M
94.21M
125.13M
Operating income
-80.14M
-83.93M
-94.21M
-125.13M
Other non operating income
-836.00K
-137.00K
-303.00K
-32.00K
EBT including unusual items
-76.53M
-80.29M
-91.10M
-121.03M
EBT excluding unusual items
-76.53M
-80.29M
-90.90M
-120.63M
Income tax expense
-
-
1.00K
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-76.53M
-80.29M
-91.10M
-121.03M
Net profit margin
-
-
-
-
Earnings per share
-1.20
-1.26
-1.39
-1.69
Interest and investment income
6.32M
5.74M
5.52M
6.36M
Interest expense
-1.87M
-1.96M
-1.90M
-1.82M
Net interest expenses
4.45M
3.78M
3.61M
4.53M
Depreciation and amortization charges
-
-
-
-
EBITDA
-80.02M
-83.80M
-94.07M
-124.99M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps